An Eight Week Randomized, Double-Blind, Double-Dummy Study Comparing a Fixed Dose Combination of Telmisartan 80mg Plus Hydrochlorothiazide 12.5mg to Telmisartan 80mg in Patients Who Fail to Respond Adequately to Treatment With Telmisartan 80mg
Latest Information Update: 21 Nov 2013
At a glance
- Drugs Telmisartan/hydrochlorothiazide (Primary) ; Telmisartan
- Indications Hypertension
- Focus Therapeutic Use
- Sponsors Boehringer Ingelheim Pharmaceuticals
- 30 Aug 2007 Status changed from recruiting to completed.
- 14 Nov 2005 New trial record.